MoneyWorks4Me

Marksans Pharma - Quaterly Results

30 May 2023 Evaluate
The sales slipped to Rs. 1530.45 millions for the March 2023 quarter as against Rs. 1762.78 millions during the year-ago period.Net profit declined -16.88% to Rs. 178.10 millions from Rs. 214.27 millions.A decline of 270.12 millions was observed in the OP in the quarter ended March 2023 from 345.16 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1530.45 1762.78 -13.18 6552.04 6582.89 -0.47 6552.04 6582.89 -0.47
Other Income 43.03 76.48 -43.74 604.82 422.51 43.15 604.82 422.51 43.15
PBIDT 270.12 345.16 -21.74 1523.85 1559.66 -2.30 1523.85 1559.66 -2.30
Interest 6.58 12.78 -48.51 36.13 37.95 -4.80 36.13 37.95 -4.80
PBDT 263.54 332.38 -20.71 1487.72 1521.71 -2.23 1487.72 1521.71 -2.23
Depreciation 35.09 46.08 -23.85 167.37 176.63 -5.24 167.37 176.63 -5.24
PBT 228.45 286.30 -20.21 1320.35 1345.08 -1.84 1320.35 1345.08 -1.84
TAX 50.35 72.03 -30.10 291.69 305.20 -4.43 291.69 305.20 -4.43
Deferred Tax -4.21 -11.26 -62.61 -1.71 5.04 -133.93 -1.71 5.04 -133.93
PAT 178.10 214.27 -16.88 1028.66 1039.88 -1.08 1028.66 1039.88 -1.08
Equity 453.16 409.31 10.71 453.16 409.31 10.71 453.16 409.31 10.71
PBIDTM(%) 17.65 19.58 -9.86 23.26 23.69 -1.84 23.26 23.69 -1.84
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..